The Chinese patent medicine Tongfengding capsule for gout in adults: a systematic review of safety and effectiveness
Abstract Background Gout is a common inflammatory arthritis caused by increased serum uric acid levels. Untreated or insufficiently treated gout can lead to deposition of monosodium urate crystals in joints, cartilage, and kidneys. Although Tongfengding capsules, a Chinese patent medicine, have long...
Main Authors: | Qiaoli Hua, Xusheng Liu, Yang Luo, Yujie Lin, Kairong Zheng, Ai Xia, Qianchun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Advances in Rheumatology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42358-023-00310-6 |
Similar Items
-
Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Xiao-Wen Zhang, et al.
Published: (2022-07-01) -
Efficacy and safety of Keluoxin capsule in combination with Western medicine for diabetic kidney disease: A systematic review and meta-analysis
by: Wenhua Zhang, et al.
Published: (2023-01-01) -
The effectiveness and safety of Chaiqin Qingning Capsule in upper respiratory tract infections with fever: A prospective, double-blinded, randomized, multicenter controlled trial
by: Xiangru Xu, et al.
Published: (2022-09-01) -
Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: a systematic review of randomized controlled trials
by: Xue Xue, et al.
Published: (2021-11-01) -
SToRytelling to Improve Disease outcomes in Gout (STRIDE-GO): a multicenter, randomized controlled trial in African American veterans with gout
by: Jasvinder A. Singh, et al.
Published: (2021-11-01)